These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 23220261

  • 1. Free speech rights outweigh restrictions on promoting drugs off label, court rules.
    Roehr B.
    BMJ; 2012 Dec 06; 345():e8324. PubMed ID: 23220261
    [No Abstract] [Full Text] [Related]

  • 2. Court rules that FDA cannot restrict off-label marketing.
    Roehr B.
    BMJ; 2015 Aug 11; 351():h4367. PubMed ID: 26265632
    [No Abstract] [Full Text] [Related]

  • 3. Off-label marketing and the First Amendment.
    Boumil MM.
    N Engl J Med; 2013 Jan 10; 368(2):103-5. PubMed ID: 23234470
    [No Abstract] [Full Text] [Related]

  • 4. The future of off-label marketing regulations in the post-Sorrell era.
    Iraggi J.
    Seton Hall Law Rev; 2013 Jan 10; 43(3):1137-63. PubMed ID: 23802338
    [No Abstract] [Full Text] [Related]

  • 5. Off-label marketing: free speech or illegal promotion?
    Silverman E.
    BMJ; 2013 Jan 22; 346():f320. PubMed ID: 23341546
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Pharmaceutical promotion and First Amendment rights.
    Troy DE, Gottlieb S.
    N Engl J Med; 2008 Jul 31; 359(5):536; author reply 536-7. PubMed ID: 18669437
    [No Abstract] [Full Text] [Related]

  • 11. Off-label prescription advertising, the FDA and the First Amendment: a study in the values of commercial speech protection.
    Klasmeier C, Redish MH.
    Am J Law Med; 2011 Jul 31; 37(2-3):315-57. PubMed ID: 21847884
    [No Abstract] [Full Text] [Related]

  • 12. United States v. Caronia: The increasing strength of commercial free speech and potential new emphasis on classifying off-label promotion as "false and misleading".
    Scheineson MJ, Cuevas G.
    Food Drug Law J; 2013 Jul 31; 68(2):201-16, iii. PubMed ID: 24640469
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Forbidden and Permitted Statements about Medications--Loosening the Rules.
    Avorn J, Sarpatwari A, Kesselheim AS.
    N Engl J Med; 2015 Sep 03; 373(10):967-73. PubMed ID: 26332553
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Pfizer versus Kaiser: insurers want their day in court.
    Silverman E.
    BMJ; 2013 Jun 12; 346():f3738. PubMed ID: 23760967
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.